Related Experiment Videos
The IL-2/IL-15 receptor systems: targets for immunotherapy
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-1374, USA. twald@helix.nih.gov
Journal of Clinical Immunology
|May 10, 2002
Summary
Interleukin-2 (IL-2) induces T-cell death for tolerance, while Interleukin-15 (IL-15) promotes T-cell survival. Understanding their opposing roles is key for immune response modulation and treating diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Interleukin-2 (IL-2) and Interleukin-15 (IL-15) are cytokines with shared receptor subunits and overlapping functions.
- Despite similarities, IL-2 and IL-15 exert contrasting effects on T-cell-mediated immune responses.
Purpose of the Study:
- To elucidate the distinct roles of IL-2 and IL-15 in T-cell immunity.
- To explore the therapeutic potential of targeting these cytokines in various diseases.
Main Methods:
- Comparative analysis of IL-2 and IL-15 functions in T-cell responses.
- Investigation of cytokine-mediated apoptosis and cell survival pathways.
- Review of current and proposed therapeutic strategies involving IL-2 and IL-15.
Main Results:
- IL-2 promotes activation-induced cell death (AICD), contributing to peripheral tolerance by eliminating self-reactive T cells.
- IL-15 generally inhibits AICD and promotes the persistence of memory phenotype CD8+ T cells.
- IL-2 and IL-15 differentially regulate the expression of memory phenotype CD8+ T cells.
Conclusions:
- IL-2 and IL-15 have opposing effects on T-cell survival and immune regulation.
- Targeting IL-2 receptor alpha (IL-2Ra) with monoclonal antibodies shows promise in allograft rejection and T-cell malignancies.
- Inhibiting IL-15 is a potential therapeutic strategy for autoimmune disorders and HTLV-1-associated diseases.